BioWorld

July 1, 2009

View Archived Issues

Ironed Out at Last: FDA Clears AMAG's Feraheme for Anemia

It was a day late - but AMAG Pharmaceuticals Inc. will hardly end up any dollars short. (BioWorld Today) Read More

Catalyst, Wyeth Partner in $500M Deal for Hemophilia Products

Exclusivity Issue Needlessly Thwarting Biogenerics Debate

Hyperion's Series C Adds $60M for Phase III Trials of HPN-100

Troubled Cell Genesys Signs Merger Deal with BioSante

Clinic Roundup

Other News To Note

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...